IO Insights

View in Browser January 9, 2025 Advertisement NEWS FROM SIO Register for the SIO 2025 Annual Scientific Meeting The countdown to the SIO 2025 Annual Scientific Meeting is ON! Join us 30 January - 3 February in Las Vegas,Nevada to learn from industry experts during cutting-edge educational sessions, pick up new practices, connect with IO leaders, and more. To secure the best available rate, we encourage you to bundle your registration with an SIO membership. Members save more on meeting costs and receive year-round benefits! Register Here Need help with registration? Contact our team at registration@sio-central.org Advertisement Join the RMSS Tonight: How to Pursue Research in Training Join the SIO Resident and Medical Student Section (RMSS) for the fourth and final session in their 2024 Talk of the Season series. Join Julius Chapiro, MD, PhD at 6:00pm ET where he will provide residents and trainees with helpful resources and information about how to jump-start your career in research early in your career. Resgister Now Take Your Education Experience to the Next Level Make the most of your time at the 2025 Annual Scientific Meeting by taking advantage of our master class offerings. If you haven't already, add one (or both) of the following to your registration. Head, Neck, and Thyroid Ablation Master Class Thursday, 30 January 2025 Strengthen your understanding of ablation practice in this area of the body, identify complications and how to mitigate them, and further develop your collaboration with surgical management. Learn More Breast Cryoablation Mini Master Class Saturday, 1 February 2025 Learn about the basics of ablative therapies, breast cancer therapies and patient selection for breast ablation through didactic presentations, case-based sessions and hands-on training. Learn More Need help with registration? Contact our team at registration@sio-central.org Advertisement Start the Year Right — Renew Your Membership Today! SIO is a big fan of you and your work! We want to keep cheering you on as you further your journey in the field of interventional oncology (IO). Renew your membership before it expires on 31 December 2024 and maintain access to a long list of exclusive benefits. Follow the steps below to renew your membership now. Log in to your SIO Member Portal Select "Membership" on the right-hand side of your profile Click "Join/Renew SIO Membership" Renew Here Hassle-Free Renewal! Choose our auto-renew option and never worry about your membership expiring. Just set it and forget it. Advertisement OPuS One Clinical Study News Promoted by Medtronic Outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation System from the OPuS One trial were recently published in the November edition of the Journal of Vascular and Interventional Radiology (JVIR). Learn more about the largest prospective study in radiofrequency ablation for bone metastases. Read More INDUSTRY NEWS Mitochondrial Gene Scoring System: Predicting Prognosis and Precision Therapy for TACE Non-Response in Hepatocellular Carcinoma Patients Journal of Cancer via PubMed The study aims to develop two independent mitochondrial scoring systems for predicting patient prognosis and the likelihood of transarterial chemoembolization nonresponse in hepatocellular carcinoma. Mitochondria-related candidate genes were analyzed using Cox and LASSO regression analyses. Read More Controlled Release of Doxorubicin From Bio-Resolvable Drug-Eluting Bead of GelMA-SPMA Graft Copolymer for Embolotherapy of Liver Cancer Journal of Drug Delivery Science and Technology via ScienceDirect Biocompatible hydrogels, including naturally occurring gelatin, are crucial in biomedical and pharmaceutical applications due to their higher biodegradability and lower immunoresponsiveness. Gelatin, a water-soluble peptide derived from animal collagen, is used in drug capsules, hemostatic pads and embolization materials. Read More Surgical Resection Versus Thermal Ablation: Comparison of Sequential Options After Successful TACE Downstaging Therapy for Unresectable Hepatocellular Carcinoma Therapeutic Advances in Medical Oncology via PubMed This study compares the effectiveness and safety of surgical resection and thermal ablation in treating hepatocellular carcinoma patients. It involved 4,782 patients who underwent TACE at 12 hospitals, with 609 patients receiving successful downstaging therapy. Read More IO Insights The Society of Interventional Oncology 2001 K Street NW, 3rd Floor North | Washington, DC 20006 USA 202-367-1164 | Contact Us www.sio-central.org Mykaila Potts Content Editor, Multiview 972-910-6876 | Contact me Unsubscribe | Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE | SUBSCRIBE | PAST ISSUES Published by